New CME/CE Offerings on HIV Prevention, HIV Treatment and HCV Cure

State of the Science in HIV: Navigating Advances in Testing and Treatment to Optimize Patient Outcomes

In this activity, which is based on recent live meetings held in Baltimore and Cambridge, Maryland, clinicians practicing on the front-lines of the intersecting hepatitis C and opioid epidemics offer thought-provoking perspectives on identifying HCV among people with substance use disorders who live in urban and rural healthcare settings and successfully engaging them in care to achieve better patient and community outcomes.

Upon completion of this activity, participants will be able to:

  • Evaluate patients with, or at risk of, hepatitis C virus (HCV) infection in order to make appropriate referrals for screening, diagnosis, treatment, or follow-up
  • Apply evidence-based strategies for supporting patients with injection drug use in harm reduction and adhering to potential HCV treatment and monitoring regimens
  • Integrate patient-centered HCV education into substance abuse/addiction center visits and programs
  • Collaborate with addiction professionals, social workers, case managers, primary care providers, infectious disease physicians, and HCV specialists to facilitate an interdisciplinary approach to HCV care and treatment for people who inject drugs (PWID)

State of the Science in HIV: Navigating Advances in Testing and Treatment to Optimize Patient Outcomes

Upon completion of this activity, participants will be able to:

  • Apply current recommendations for HIV testing of adults, adolescents, and pregnant women, recognizing the possibility of more frequent testing for high-risk persons
  • Describe currently available HIV testing technologies and the recommended testing algorithm
  • Initiate ART in all HIV-infected individuals, considering each patient’s clinical and laboratory characteristics, history, health status (ie, co-occurring or comorbid conditions) and preference in order to maximize efficacy and adherence
  • Apply recent efficacy and safety data on the timing and choice of ART in initial regimens and switch strategies for HIV-infected patients
  • Assess the potential impact of clinical trial data related to emerging therapeutic strategies for HIV

HCV from Screening to Cure: A Closer Look at Changing At-risk Populations and an Evolving Treatment Landscape

Upon completion of this activity, participants will be able to:

  • Recommend appropriate screening for hepatitis C virus infection based on current guidelines
  • Summarize the hepatitis C testing sequence for identifying current infection
  • Select optimal treatment for individual patients with HCV infection in the context of current guidelines and clinical trial results

Breaking Down the Barriers to PrEP: The Patient Journey from Misconceptions to Effective HIV Prevention

Upon completion of this activity, participants will be able to: 

  • Apply strategies (ie, effective sexual history-taking; sexual minority competence) to assess HIV risk behaviors and identify specific patients who are appropriate candidates for pre-exposure prophylaxis (PrEP)
    Implement effective PrEP education and counseling to address misconceptions and stigma
  • Apply evidence-based and consensus guidelines regarding the appropriate use of PrEP in people at high risk for HIV acquisition
  • Employ successful patient communication techniques that motivate and increase adherence to HIV prevention strategies

Questions? Contact Marissa Tonelli, Director of Health Systems Capacity Building, 202.507.4731, marissa@healthhiv.org.